A Study To Evaluate The Effectiveness Of An Investigational Product In The Treatment Of Male Pattern Hair Loss

This study has been completed.
Sponsored by: Pfizer
Information provided by: Pfizer
ClinicalTrials.gov Identifier: NCT00151515

Purpose
The primary purpose of the study is to evaluate the efficacy of an investigational product in males for the treatment of pattern hair loss. The secondary purpose is to evaluate the safety of an investigational product in males when used twice daily for the treatment of pattern hair loss and to obtain safety data on the investigational product when used twice daily for up to one year.
Condition Intervention Phase
Androgenetic Alopecia
Drug: Investigational product; name omitted due to commercial sensitivity and will be revealed at a later date
Phase III

MedlinePlus related topics: Hair Diseases and Hair Loss
Genetics Home Reference related topics: Hair Diseases and Hair Loss

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Official Title: A Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of an Investigational Product in the Treatment of Androgenetic Alopecia in Males
Further study details as provided by Pfizer:
Primary Outcomes: Information was omitted due to commercial sensitivity and will be revealed at a later date
Secondary Outcomes: Information was omitted due to commercial sensitivity and will be revealed at a later date
Expected Total Enrollment: 360

Study start: October 2003; Study completion: July 2004

Eligibility
Ages Eligible for Study: 15 Years - 49 Years, Genders Eligible for Study: Male

Accepts Healthy Volunteers
Criteria

Inclusion Criteria:

* Presence of androgenetic alopecia with vertex pattern IIIv, IV, or V on the Norwood Hamilton Scale

Exclusion Criteria:

* Known sensitivity to the investigational product.

Location Information

Study chairs or principal investigators

Pfizer CT.gov Call Center, Study Director, Pfizer

More Information
Study ID Numbers: AAAA1001
Last Updated: July 24, 2006
Record first received: September 8, 2005
ClinicalTrials.gov Identifier: NCT00151515
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2006-10-13 Link To Clinical Trails

-- Edited by EuroHair at 14:41, 2006-10-15